Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ubiquinone (1 trial)
etanercept (enbrel) (1 trial)
sodium chloride (1 trial)
Charcot-Marie-Tooth Disease (Phase 2)
Hereditary Sensory and Motor Neuropathy (Phase 2)
Nerve Compression Syndromes (Phase 2)
Tooth Diseases (Phase 2)
Trials (2 total)
Trial APIs (3 total)